• L01EA Bcr-abl tyrosine kinase inhibitors 25 drugs
• L01EB Epidermal growth factor receptor (egfr) tyrosine kinase inhibitors 10 drugs
• L01EC B-raf serine-threonine kinase (braf) inhibitors 4 drugs
• L01ED Anaplastic lymphoma kinase (alk) inhibitors 5 drugs
• L01EE Mitogen-activated protein kinase (mek) inhibitors 5 drugs
• L01EF Cyclin-dependent kinase (cdk) inhibitors 3 drugs
• L01EG Mammalian target of rapamycin (mtor) kinase inhibitors 7 drugs
• L01EH Human epidermal growth factor receptor 2 (her2) tyrosine kinase inhibitors 3 drugs
• L01EJ Janus-associated kinase (jak) inhibitors 4 drugs
• L01EK Vascular endothelial growth factor receptor (vegfr) tyrosine kinase inhibitors 5 drugs
• L01EL Bruton's tyrosine kinase (btk) inhibitors 4 drugs
• L01EM Phosphatidylinositol-3-kinase (pi3k) inhibitors 2 drugs
• L01EN 3 drugs
• L01EX Other protein kinase inhibitors 52 drugs